A detailed history of Whittier Trust CO transactions in Organon & Co. stock. As of the latest transaction made, Whittier Trust CO holds 1,780 shares of OGN stock, worth $26,290. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,780
Previous 2,094 15.0%
Holding current value
$26,290
Previous $43,000 20.93%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$18.65 - $23.03 $5,856 - $7,231
-314 Reduced 15.0%
1,780 $34,000
Q2 2024

Jul 26, 2024

SELL
$17.45 - $21.96 $4,292 - $5,402
-246 Reduced 10.51%
2,094 $43,000
Q1 2024

May 02, 2024

SELL
$13.78 - $18.8 $8,323 - $11,355
-604 Reduced 20.52%
2,340 $43,000
Q4 2023

Jan 11, 2024

SELL
$10.95 - $17.32 $33,233 - $52,566
-3,035 Reduced 50.76%
2,944 $42,000
Q3 2023

Oct 27, 2023

SELL
$16.59 - $23.77 $14,848 - $21,274
-895 Reduced 13.02%
5,979 $103,000
Q2 2023

Jul 24, 2023

SELL
$19.27 - $24.63 $19,308 - $24,679
-1,002 Reduced 12.72%
6,874 $143,000
Q1 2023

Apr 21, 2023

SELL
$21.42 - $32.08 $7,154 - $10,714
-334 Reduced 4.07%
7,876 $185,000
Q4 2022

Jan 25, 2023

SELL
$23.31 - $28.61 $18,251 - $22,401
-783 Reduced 8.71%
8,210 $0
Q3 2022

Oct 21, 2022

SELL
$23.4 - $34.25 $22,838 - $33,428
-976 Reduced 9.79%
8,993 $210,000
Q2 2022

Jul 28, 2022

SELL
$31.66 - $38.9 $45,875 - $56,366
-1,449 Reduced 12.69%
9,969 $337,000
Q1 2022

Apr 29, 2022

SELL
$30.45 - $39.36 $36,296 - $46,917
-1,192 Reduced 9.45%
11,418 $399,000
Q4 2021

Jan 19, 2022

SELL
$28.67 - $37.13 $90,396 - $117,070
-3,153 Reduced 20.0%
12,610 $383,000
Q3 2021

Nov 01, 2021

SELL
$28.63 - $35.64 $107,448 - $133,756
-3,753 Reduced 19.23%
15,763 $517,000
Q2 2021

Jul 29, 2021

BUY
$28.45 - $38.0 $555,230 - $741,608
19,516 New
19,516 $590,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.